Feasibility of continuous temperature monitoring in pediatric immunocompromised patients: A pilot study

Early recognition of fever is paramount in reducing morbidity and mortality in immunocompromised patients. We performed a pilot study to determine the feasibility, safety, and tolerability of continuous temperature monitoring via TempTraq, a continuous temperature monitoring patch. Ten pediatric pat...

Full description

Saved in:
Bibliographic Details
Published inPediatric blood & cancer Vol. 66; no. 6; pp. e27723 - n/a
Main Authors Sampson, Megan, Hickey, Victoria, Huber, John, Alonso, Priscila Badia, Davies, Stella M., Dandoy, Christopher E.
Format Journal Article
LanguageEnglish
Published United States 01.06.2019
Subjects
Adolescent
Child
Child, Preschool
Feasibility Studies
Female
fever
Fever - diagnosis
Fever - etiology
Follow-Up Studies
Hematologic Neoplasms - therapy
Hematopoietic Stem Cell Transplantation - adverse effects
Humans
Immunocompromised Host
Infant
infections
Male
Monitoring, Physiologic
Pilot Projects
Prognosis
Prospective Studies
Retrospective Studies
stem cell transplantation
Temperature
infections
fever
stem cell transplantation
Online AccessGet full text

Cover

More Information
Summary:Early recognition of fever is paramount in reducing morbidity and mortality in immunocompromised patients. We performed a pilot study to determine the feasibility, safety, and tolerability of continuous temperature monitoring via TempTraq, a continuous temperature monitoring patch. Ten pediatric patients were enrolled and received continuous temperature monitoring over 5 days in addition to episodic monitor (standard of care). Episodic monitoring failed to detect fever in two patients and there was a significant delay (>12 h) of fever detection in two others that was detected with TempTraq. Additionally, caregivers reported TempTraq was tolerable and easy to apply.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
ISSN:1545-5009
1545-5017
DOI:10.1002/pbc.27723